Publications
2024
- Using qualitative system dynamics modeling to understand overdose bystander behavior in the context of Connecticut's Good Samaritan Laws and identify effective policy options.Thompson RL, Sabounchi NS, Ali SS, Heimer R, D'Onofrio G, Heckmann R. Harm Reduct J. 2024 Jun 27; 2024 Jun 27. PMID: 38937759.
- Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.Haque LY, Leggio L. Hepatology. 2024 Jun 27; 2024 Jun 27. PMID: 38935926.
- An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes.Kypriotakis G, Bernstein SL, Bold KW, Dziura JD, Hedeker D, Mermelstein RJ, Weinberger AH. Nicotine Tob Res. 2024 Jun 21. PMID: 38214037.
- Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial.Balter DR, Puglisi LB, Dziura J, Fiellin DA, Howell BA. J Subst Use Addict Treat. 2024 Jun 8; 2024 Jun 8. PMID: 38857827.
- Trends in the Prescribing of Buprenorphine for Opioid Use Disorder, 2019-2023.Savitz ST, Stevens MA, Nath B, D'Onofrio G, Melnick ER, Jeffery MM. Mayo Clin Proc Innov Qual Outcomes. 2024 Jun; 2024 May 24. PMID: 38841599.
- The MATE Act: Progress for substance use education, but is checking a box enough?Morford KL, Tetrault JM, Fiellin DA. J Gen Intern Med. 2024 Jun; 2024 Feb 2. PMID: 38308156.
- Prescription Opioid Dose Change Prior to Fatal Opioid-Detected Overdose.Kazemitabar M, Howell BA, Becker WC, Lin HJ, Grau LE, Heimer R, D'Onofrio G, Hawk K, Fiellin DA, Black AC. J Stud Alcohol Drugs. 2024 May 22; 2024 May 22. PMID: 38775307.
- Alcohol-Related Care Among Veterans With Unhealthy Alcohol Use: The Role of Long-Term Opioid Therapy Receipt.Joudrey PJ, Wang M, DeRycke E, Williams EC, Edelman EJ. J Addict Med. 2024 May-Jun 01; 2024 Mar 27. PMID: 38533996.
- Opportunities for Alcohol-Related Care in the COVID-19 Pandemic and Beyond.Oldfield B, Haque L, Jennifer Edelman E. J Gen Intern Med. 2024 Apr 26; 2024 Apr 26. PMID: 38671202.
- Stepped Care for Patients to Optimize Whole Recovery (SC-POWR): An Effectiveness Trial Evaluating a Stepped Care Model for Individuals With Opioid Use Disorder and Chronic Pain.Rossi R, Cutter CJ, Beitel M, Covelli M, Fiellin DA, Kerns RD, Vassilieva S, Olabisi D, Barry DT. Subst Use Addctn J. 2024 Apr 12; 2024 Apr 12. PMID: 38606900.
- The dementia care study (D-CARE): Recruitment strategies and demographic characteristics of participants in a pragmatic randomized trial of dementia care.Yang M, Samper-Ternent R, Volpi E, Green AN, Lichtenstein M, Araujo K, Borek P, Charpentier P, Dziura J, Gill TM, Galloway R, Greene EJ, Lenoir K, Peduzzi P, Meng C, Reese J, Shelton A, Skokos EA, Summapund J, Unger E, Reuben DB, Williamson JD, Stevens AB. Alzheimers Dement. 2024 Apr; 2024 Feb 15. PMID: 38358084.
- Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action.Haque LY, Zuluaga P, Muga R, Fuster D. Addict Sci Clin Pract. 2024 Mar 19; 2024 Mar 19. PMID: 38504384.
- Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations.McLeman B, Gauthier P, Lester LS, Homsted F, Gardner V 3rd, Moore SK, Joudrey PJ, Saldana L, Cochran G, Harris JP, Hefner K, Chongsi E, Kramer K, Vena A, Ottesen RA, Gallant T, Boggis JS, Rao D, Page M, Cox N, Iandiorio M, Ambaah E, Ghitza U, Fiellin DA, Marsch LA. Addict Sci Clin Pract. 2024 Mar 18; 2024 Mar 18. PMID: 38500166.
- Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque LY, Balliet W, Serper M. Liver Transpl. 2024 Mar 13; 2024 Mar 13. PMID: 38471008.
- Racial and Ethnic Differences in Heroin, Methamphetamine, and Cocaine Use, Treatment, and Mortality Trends in 3 National Data Sources-United States, 2010-2019.Shearer RD, Segel JE, Howell BA, Jones AA, Khatri UG, Teixeira da Silva D, Vest N, Winkelman TNA. Med Care. 2024 Mar 1; 2024 Jan 5. PMID: 38180005.
- Leveraging a Learning Collaborative Model to Develop and Pilot Quality Measures to Improve Opioid Prescribing in the Emergency Department.Hawk KF, Weiner SG, Rothenberg C, Bernstein E, D'Onofrio G, Herring A, Hoppe J, Ketcham E, LaPietra A, Nelson L, Perrone J, Ranney M, Samuels EA, Strayer R, Sharma D, Goyal P, Schuur J, Venkatesh AK. Ann Emerg Med. 2024 Mar; 2023 Oct 11. PMID: 37831040.
- Formative evaluation of an emergency department clinical decision support system for agitation symptoms: a study protocol.Wong AH, Nath B, Shah D, Kumar A, Brinker M, Faustino IV, Boyce M, Dziura JD, Heckmann R, Yonkers KA, Bernstein SL, Adapa K, Taylor RA, Ovchinnikova P, McCall T, Melnick ER. BMJ Open. 2024 Feb 19; 2024 Feb 19. PMID: 38373857.
- Accessibility of Opioid Treatment Programs Based on Conventional vs Perceived Travel Time Measures.Kim J, Lee J, Thornhill TA, Dennett J, Lu H, Howell B, Grau LE, Fiellin DA, Heimer R, Gonsalves G. JAMA Netw Open. 2024 Feb 5; 2024 Feb 5. PMID: 38376839.
- Opioid prescription and risk of atrial fibrillation in younger veterans.Chui PW, Khokhar A, Gordon KS, Dziura J, Burg MM, Brandt C, Haskell SG, Malm B, Bastian LA, Gandhi PU. Am Heart J. 2024 Feb; 2023 Nov 9. PMID: 37949420.
- A Serious Video Game Targeting HIV Testing and Counseling: A Randomized Controlled Trial.Boomer TP, Larkin K, Duncan LR, Fernandes CF, Fiellin LE. J Adolesc Health. 2024 Feb; 2023 Oct 10. PMID: 37815773.